Skip to main content

Table 2 Relationship of EPCAM expression with pathological parameters of tumor

From: L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients

Clinical parameters EPCAM
  Low High t/χ2/r P
Age(yrs) 56.85 ± 11.4 61.51 ± 12.22 4.787 0.0001
Gender    0.805 0.370
Male 257 (60.0%) 171 (40.0%)   
Female 97 (56.1%) 76 (43.9%)   
Location    10.37 0.006
Proximal 37 (44.0%) 47 (56.0%)   
Middle 130 (58.3%) 93 (41.7%)   
Distal 187 (63.6%) 107 (36.4%)   
Size    40.47 0.0001
<5 cm 244 (69.7%) 106 (30.3%)   
≥5 cm 110 (43.8%) 141 (56.2%)   
Lauren classification    198.1 0.0001
Intestinal 261 (87.3%) 38 (12.7%)   
Diffuse 93 (30.8%) 209 (69.2%)   
Histology    3.136 0.371
Papillary adenocarcinoma 20 (69.0%) 9 (31.0%)   
Tubular adenocarcinoma 254 (57.9%) 185 (42.1%)   
Mucinous adenocarcinoma 19 (51.4%) 18 (48.6%)   
Signet-ring cell carcinoma 61 (63.5%) 35 (36.5%)   
Histologic differentiation    6.323 0.097
Well 12 (70.6%) 5 (29.4%)   
Moderately 113 (64.6%) 62 (35.4%)   
Poorly 227 (55.8%) 180 (44.2%)   
Others 2 (100.0%) 0 (0.0%)   
Invasion depth    107.1 0.0001
T1 73 (91.2%) 7 (8.8%)   
T2 113 (80.1%) 28 (19.9%)   
T3 160 (47.3%) 178 (52.7%)   
T4 8 (19.0%) 34 (81.0%)   
TNM stages    201.6 0.0001
I 119 (93.7%) 8 (6.3%)   
II 116 (85.9%) 19 (14.1%)   
III 99 (42.9%) 132 (57.1%)   
IV 20 (18.5%) 88 (81.5%)   
Lymphatic metastasis    119.1 0.0001
No 193 (87.7%) 27 (12.3%)   
Yes 161 (42.3%) 220 (57.5%)   
Regional lymph nodes    182.6 0.0001
PN0 193 (87.7%) 27 (12.3%)   
PN1 118 (59.6%) 80 (40.4%)   
PN2 42 (31.1%) 93 (68.9%)   
PN3 1 (2.1%) 47 (97.9%)   
Distant metastasis    53.42 0.0001
No 332 (65.1%) 178 (34.9%)   
Yes 22 (24.2%) 69 (75.8%)